Blog Posts - Pharma Industry Trends



Is Eliquis Safer Than Xarelto And Pradaxa If It Causes Fewer Dangerous Major Bleeding Events

Perhaps, But Neither Eliquis Nor Xarelto Have Any Specific Reversal Agent To Stop An Acute Bleed Once It Starts; Only Pradaxa Does (Posted by Tom Lamb at DrugInjuryWatch.com) During the American Heart Association 2015 Scientific Sessions in Orlando,...
by Drug Injury Watch on Nov 10, 2015

New Anti-Clotting Drug Savaysa Can Be Dangerous As It Has No Treatment Approved To Reverse The Anti-Coagulant Effect In Cases Of Bleeding

Like Eliquis, Xarelto, And Pradaxa, This New Blood-Thinner Is Being Sold By Drug Companies At A Time When Profits May Be Taking Priority Over Patient Safety (Posted by Tom Lamb at DrugInjuryWatch.com) Savaysa (edoxaban) is from the drug company Daiic...
by Drug Injury Watch on Aug 13, 2015

Multaq: Increased Risks Of Side Effects, Including Death, Outweigh Any Benefits Say Researchers Who Reviewed Clinical Data

In Addition, They Are Highly Critical Of Relationship The Sanofi Aventis Drug Company Had With Those Doctors Who Developed Prescribing Guidelines (Posted by Tom Lamb at DrugInjuryWatch.com) As we know, now, since being approved by the FDA in 2009 and...
by Drug Injury Watch on Mar 6, 2014

"Selling Sickness 2013" Conference In February Will Focus On Various Aspects Of Pharmaceutical Industry

Academic Medical Reformers, Consumer Activists, Health Journalists, And Others Will Gather In Washington, DC To Discuss Big Pharma Conduct and Practices (Posted by Tom Lamb at DrugInjuryWatch.com) I want to let you know about an event we will coverin...
by Drug Injury Watch on Jan 23, 2013

Two New Books About Drug Injury Lawsuits, "All The Justice Money Can Buy" and "The Trial"

First Covers One Of The Early Vioxx Cases, Second Is Legal Thriller Fiction With Parallels To Ketek Fiasco (Posted by Tom Lamb at DrugInjuryWatch.com) As the summer reading season draws near, we take a break from our usual reporting to let you know a...
by Drug Injury Watch on May 23, 2011

Medical Journal Withdraws Article About Januvia And Byetta After It Gets Letters From Two Drug Companies

April 2011 Edition Of BMJ Breaks News And Provides Insight From One Who Saw An Increased Risk Of Pancreatitis (Posted by Tom Lamb at DrugInjuryWatch.com) According to a news item published April 11, 2011 by The British Medical Journal (BMJ), letters...
by Drug Injury Watch on May 2, 2011

Some Seroquel Documents From AstraZeneca Now Available At The Drug Industry Document Archive

These 241 "New" Documents Show How Drug Company Obscured Potential For Patient Weight Gain And Diabetes(Posted by Tom Lamb at DrugInjuryWatch.com) In mid-February 2010 Kim Klausner, the Industry Documents Digital Libraries Manager for Drug...
by Drug Injury Watch on Mar 11, 2010

Recent Report About Ortho Evra Safety Seems To Contradict Earlier Findings From Same Group

Third Boston Collaborative Drug Surveillance Program Study Analysis Concerning Ortho Evra And Blood Clot Side Effect Risk Causes Confusion(Posted by Tom Lamb at DrugInjuryWatch.com) Let us start with this relatively recent medical journal article, &q...
by Drug Injury Watch on Mar 8, 2010

GE Healthcare Seemingly Tries To Intimidate And Silence A Critic Of Its Omniscan Product

Drug Company Files Libel Lawsuit In UK Against Prominent Danish Radiologist Henrik Thomsen (Posted by Tom Lamb at DrugInjuryWatch.com) The Sunday Times (UK) recently ran a story that demonstrates how Britain's libel laws are possibly being used by GE...
by Drug Injury Watch on Jan 11, 2010

FDA Wants Studies Done On Byetta Safety, With Focus On Pancreatitis, Pancreatic Cancer, Thyroid Neoplasm, And Acute Renal Failure

FDA Letter About Byetta Sent To Amilyn In October 2009; Drug Company Tries To Downplay, But Investors React When They Learn About It In December 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) On October 30, 2009 Amylin Pharmaceuticals Inc. issued a...
by Drug Injury Watch on Jan 6, 2010

Drug Industry Document Archive (DIDA) Adds 15 More Pharma-Related Documents To Collection In November 2009

This Archive Contains Some "Secret" Documents Only Made Public In The Course Of Lawsuits Filed Against Pharmaceutical Companies (Posted by Tom Lamb at DrugInjuryWatch.com) Created and maintained by the University of California at San Franci...
by Drug Injury Watch on Nov 20, 2009

FDA Should Make Drug Efficacy And Safety Information More Accessible To Patients

Package Inserts Prepared By Drug Companies Which Exagerrate Benefits And Downplay Risks Need To Be Addressed (Posted by Tom Lamb at DrugInjuryWatch.com) In the October 21, 2009 edition of The New England Journal of Medicine (NEJM) there is a Perspect...
by Drug Injury Watch on Oct 27, 2009

Drug-Company Sponsored Ghostwriters Are Getting Busted By Some Medical Journals

Drug Industry Document Archive (DIDA) Adds Newly Released Wyeth Ghostwriting Documents In September 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) A September 18, 2009 article, "Medical Editors Push for Crackdown on Ghostwriting", publish...
by Drug Injury Watch on Sep 18, 2009

Drug-Company Sponsored Ghostwriters Are Getting Busted By Some Medical Journals

Drug Industry Document Archive (DIDA) Adds Newly Released Wyeth Ghostwriting Documents In September 2009 (Posted by Tom Lamb at DrugInjuryWatch.com) A September 18, 2009 article, "Medical Editors Push for Crackdown on Ghostwriting", publish...
by Drug Injury Watch on Sep 18, 2009

Drug Industry Document Archive Has Over 1500 Documents Regarding Big Pharma Conduct

Includes Previously Secret Documents That Were Released During Lawsuits Against Merck & Co., Parke-Davis, Warner-Lambert, and Pfizer (Posted by Tom Lamb at DrugInjuryWatch.com) The Drug Industry Document Archive (DIDA), created by the University...
by Drug Injury Watch on Sep 11, 2009

Drug Industry Document Archive Has Over 1500 Documents Regarding Big Pharma Conduct

Includes Previously Secret Documents That Were Released During Lawsuits Against Merck & Co., Parke-Davis, Warner-Lambert, and Pfizer (Posted by Tom Lamb at DrugInjuryWatch.com) The Drug Industry Document Archive (DIDA), created by the University...
by Drug Injury Watch on Sep 11, 2009

Public Surveys Indicate The Need For Reform In Drug Safety By Big Pharma And The FDA

Healthcare Providers And Patients Are Encouraged To Report Adverse Events Involving Approved Or Unapproved Indications As Well As Medication Errors (Posted by Tom Lamb at DrugInjuryWatch.com) In October 2006 Quintiles Inc., a leading CRO company, con...
by Drug Injury Watch on Sep 8, 2009

Public Surveys Indicate The Need For Reform In Drug Safety By Big Pharma And The FDA

Healthcare Providers And Patients Are Encouraged To Report Adverse Events Involving Approved Or Unapproved Indications As Well As Medication Errors (Posted by Tom Lamb at DrugInjuryWatch.com) In October 2006 Quintiles Inc., a leading CRO company, con...
by Drug Injury Watch on Sep 8, 2009

Can New FDA Transparency Task Force Acheive Its Lofty Objectives?

While Need For Greater Disclosure By FDA Is Evident, Drug Maker Trade Secrets May Be Difficult Obstacle To Overcome (Posted by Tom Lamb at DrugInjuryWatch.com) In early June 2009 it was announced that the FDA would begin to set up...
by Drug Injury Watch on Jun 4, 2009

Can New FDA Transparency Task Force Acheive Its Lofty Objectives?

While Need For Greater Disclosure By FDA Is Evident, Drug Maker Trade Secrets May Be Difficult Obstacle To Overcome (Posted by Tom Lamb at DrugInjuryWatch.com) In early June 2009 it was announced that the FDA would begin to set up...
by Drug Injury Watch on Jun 4, 2009


Trending Topics

Close